These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 7706853

  • 1. [Effects of long-term administration of tamoxifen on vaginal epithelium and complications of endometrial lesions in breast cancer patients].
    Yokosuka K, Teshima H, Katase K, Fujimoto I, Yamauchi K, Hasumi K, Tatsuki Y.
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):125-32. PubMed ID: 7706853
    [Abstract] [Full Text] [Related]

  • 2. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen.
    Lahti E, Vuopala S, Kauppila A, Blanco G, Ruokonen A, Laatikainen T.
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):410-4. PubMed ID: 7835781
    [Abstract] [Full Text] [Related]

  • 3. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
    Taponeco F, Curcio C, Fasciani A, Giuntini A, Artini PG, Fornaciari G, Petraglia F, Genazzani AR.
    J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
    [Abstract] [Full Text] [Related]

  • 4. Tamoxifen and endometrial pathologies: a prospective study.
    Seoud M, Shamseddine A, Khalil A, Salem Z, Saghir N, Bikhazi K, Bitar N, Azar G, Kaspar H.
    Gynecol Oncol; 1999 Oct; 75(1):15-9. PubMed ID: 10502419
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer.
    Deligdisch L, Kalir T, Cohen CJ, de Latour M, Le Bouedec G, Penault-Llorca F.
    Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800
    [Abstract] [Full Text] [Related]

  • 7. Long-term follow-up of postmenopausal breast cancer patients following discontinuation of tamoxifen therapy.
    Markovitch O, Tepper R, Fishman A, Aviram R, Cohen I.
    Maturitas; 2008 Apr 20; 59(4):387-93. PubMed ID: 18490117
    [Abstract] [Full Text] [Related]

  • 8. Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen.
    Lahti E, Blanco G, Kauppila A, Apaja-Sarkkinen M, Taskinen PJ, Laatikainen T.
    Obstet Gynecol; 1993 May 20; 81(5 ( Pt 1)):660-4. PubMed ID: 8469450
    [Abstract] [Full Text] [Related]

  • 9. [Risk of endometrial hyperplasia and carcinoma in breast cancer patients receiving adjuvant tamoxifen].
    Semiglazov VF, Maksimov SIa, Bulgatova EA, Meshkova IE, Chepik OF, Berstein LM.
    Vopr Onkol; 2003 May 20; 49(2):198-204. PubMed ID: 12785205
    [Abstract] [Full Text] [Related]

  • 10. Comparison of endometrial changes among symptomatic tamoxifen-treated and nontreated premenopausal and postmenopausal breast cancer patients.
    Cheng WF, Lin HH, Torng PL, Huang SC.
    Gynecol Oncol; 1997 Aug 20; 66(2):233-7. PubMed ID: 9264568
    [Abstract] [Full Text] [Related]

  • 11. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E, Libera H, Kimmig R, Forsting M.
    Rofo; 2006 Mar 20; 178(3):316-23. PubMed ID: 16508840
    [Abstract] [Full Text] [Related]

  • 12. Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women.
    Marttunen MB, Cacciatore B, Hietanen P, Pyrhönen S, Tiitinen A, Wahlström T, Ylikorkala O.
    Br J Cancer; 2001 Apr 06; 84(7):897-902. PubMed ID: 11286468
    [Abstract] [Full Text] [Related]

  • 13. Steroid receptor expression in endometria from women treated with tamoxifen.
    Kommoss F, Karck U, Prömpeler H, Pfisterer J, Kirkpatrick CJ.
    Gynecol Oncol; 1998 Aug 06; 70(2):188-91. PubMed ID: 9740688
    [Abstract] [Full Text] [Related]

  • 14. [Clinicopathological features of endometrial carcinoma in tamoxifen- and toremifene-treated breast cancer patients].
    Otsuka I, Takahashi S, O'uchi K, Akimoto N, Hanari K, Ogaki Y, Enatsu YH, Takigawa A, Takaya H, Tanaka A, Kaseki H, Yamada T.
    Gan To Kagaku Ryoho; 2010 Feb 06; 37(2):279-83. PubMed ID: 20154485
    [Abstract] [Full Text] [Related]

  • 15. [Ultrasound endometrium follow-up during tamoxifen treatment: Really not reliable or useful after all?].
    Burkart C, Wight E, Pók J, Kernen B, Traber M, Haller U, Bajka M.
    Ultraschall Med; 2001 Jun 06; 22(3):136-42. PubMed ID: 11484445
    [Abstract] [Full Text] [Related]

  • 16. Effects of hormone therapy on the endometrium.
    Deligdisch L.
    Mod Pathol; 1993 Jan 06; 6(1):94-106. PubMed ID: 8426860
    [Abstract] [Full Text] [Related]

  • 17. Reciprocal effects of tamoxifen on hormonal cytology in postmenopausal women.
    Shiota A, Igarashi T, Kurose T, Ohno M, Hando T.
    Acta Cytol; 2002 Jan 06; 46(3):499-506. PubMed ID: 12040644
    [Abstract] [Full Text] [Related]

  • 18. Endometrial pathology at dilatation and curettage in breast cancer patients: comparison of tamoxifen users and nonusers.
    Gibson LE, Barakat RR, Venkatraman ES, Hoskins WJ.
    Cancer J Sci Am; 1996 Jan 06; 2(1):35-8. PubMed ID: 9166496
    [Abstract] [Full Text] [Related]

  • 19. [Endometrial cancer and tamoxifen. Discussion apropos of a series of cases].
    Sasco AJ, Ah-Song R, Gendre I, Zlatoff P, Bobin JY, Hallonet P, Leduc B.
    Bull Cancer; 1997 Jan 06; 84(1):51-60. PubMed ID: 9180860
    [Abstract] [Full Text] [Related]

  • 20. [Cancer of the endometrium caused by antiestrogens].
    Le Bouëdec G, Dauplat J.
    Rev Fr Gynecol Obstet; 1992 Jun 06; 87(6):345-8. PubMed ID: 1631476
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.